3 Matching Annotations
- May 2021
-
www.frontiersin.org www.frontiersin.org
-
Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
I think this may be the best review of salvinorin A that I have ever looked at. I definitely need to sit down and read the full article at some point.
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
In contrast to its acute administration, repeated salvinorin A administration did not modify dialysate DA levels. Similarly, neither basal extracellular DA levels nor DA uptake was altered. Unlike synthetic KOPr agonists, prior repeated administration of salvinorin A did not attenuate the locomotor activating effects of an acute cocaine (20 mg/kg, i.p.) challenge. However, cocaine-evoked DA overflow was enhanced.
Fascinating and useful stuff. This is close to what I was expecting. Though, I was expecting chronic exposure to upregulate dopamine beyond baseline. If I'm understanding this correctly, it was upregulated in the sense that it enhanced the dopaminergic effects of cocaine. I've not yet read the full study.
-
- Mar 2019
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Somaesthesia
Presumably this captures the "gravity" effects of low dose salvia. This is the metric that interests me most.
-